Results 31 to 40 of about 2,726 (200)

Symptomatic hypophosphataemia after intravenous iron therapy: an underrated adverse reaction

open access: yesEndocrinology, Diabetes & Metabolism Case Reports, 2019
Iron (ferric carboxymaltose) infusion therapy is used to treat severe iron deficiency which is not responding to the first-line oral iron therapy. However, it can also cause severe renal wasting of phosphate resulting in severe hypophosphataemia in some ...
Eseoghene Ifie   +3 more
doaj   +1 more source

Postoperative hypophosphataemia

open access: yesJournal of British Surgery, 1979
Summary The possible mechanisms of postoperative hypophosphataemia were studied in women undergoing uncomplicated cholecystectomy. Six patients were allocated to each of three groups. Group I received no intravenous fluids, group II received dextrose/saline solution alone and group III received dextrose/saline solution with phosphorus ...
P C, England   +4 more
openaire   +2 more sources

Dyspnea and Generalized Paresthesias Due to a Rare Metabolic Disorder: Severe Hypophosphatemia

open access: yesMedicine Science, 2016
We present a patient with severe hypophosphatemia related hypoxic respiratory failure resolving with phosphate replacement. [Med-Science 2016; 5(2.000): 747-50]
Seyit Ahmet Uslu   +3 more
doaj   +1 more source

Worsening of unrecognized tumour-induced osteomalacia with inadvertent use of recombinant human parathyroid hormone

open access: yesEndokrynologia Polska, 2020
Not required for Clinical Vignette.
Rimesh Pal   +5 more
doaj   +1 more source

Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FID. [PDF]

open access: yesEur J Heart Fail
Changes in serum phosphate levels over time with ferric carboxymaltose (FCM) in a randomized, double‐blind, prospective substudy of HEART‐FID assessing the following outcomes: serum phosphate, 1,25 dihydroxyvitamin D, 25‐hydroxyvitamin D levels and plasma levels of intact parathyroid hormone during 6 months subsequent to FCM infusion.
Nouhravesh N   +16 more
europepmc   +2 more sources

Early hypophosphataemia in at risk newborns. Frequency and magnitude

open access: yesAnales de Pediatría (English Edition), 2018
Objective: To determine the frequency and magnitude of neonatal hypophosphataemia (
Gerardo Bustos Lozano   +5 more
doaj   +1 more source

Hipofosforemia precoz en recién nacidos de riesgo. Frecuencia y magnitud

open access: yesAnales de Pediatría, 2018
Resumen: Objetivo: Conocer la frecuencia y la magnitud de la hipofosforemia neonatal (
Gerardo Bustos Lozano   +5 more
doaj   +1 more source

SOME STUDIES ON THE CAUSES OF HAEMATURIA AND HAEMOGLOBINURIA IN CATTLE AND BUFFALOES IN ASSIUT [PDF]

open access: yesAssiut Veterinary Medical Journal, 1977
This work is designed to study the possible causes of haematuria and haemoglobinuria and also the changes that may occur in blood and serum of 187 cattle and buffaloes in Assiut province.
EI-AMROUSI, S.M.HASSAN   +2 more
doaj   +1 more source

The influence of parenteral protein intake on electrolyte disturbances in premature infants

open access: yesAnales de Pediatría (English Edition), 2021
Introduction: Aggressive parenteral nutrition with delivery of high amino acid and energy doses is used to improve growth and neurodevelopmental outcomes in very low birth weight (VLBW) preterm infants.
Carlos Javier Parramón-Teixidó   +6 more
doaj   +1 more source

A new metabolic path in type 3 rickets. [PDF]

open access: yesFEBS J
Rickets, a bone disorder, was historically categorised into either nutritional (vitamin D deficiency) or genetic forms involving loss‐of‐function mutations in mineral metabolism. Recently, a new mechanism, type 3 rickets, was discovered to be caused by a gain‐of‐function mutation in CYP3A4 (Ile301Thr).
Senda T, Hirota Y.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy